Evidence map›Paper›PMID 30898870›Full record

ArticleJournal of the American Society of Nephrology : JASN2019

Improving CKD-Specific Patient-Reported Measures of Health-Related Quality of Life.

John E Ware, Michelle M Richardson, Klemens B Meyer, Barbara Gandek

Abstract readComparative StudyMulticenter StudyValidation Study
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Clinical events and patient-reported outcome measures during CKD progression: findings from the Chronic Renal Insufficiency Cohort Study.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2021
    Article
  12. Determinants of patient activation and its association with cardiovascular disease risk in chronic kidney disease: A cross-sectional study.Health expectations : an international journal of public participation in health care and health policy · 2021
    Article
  13. The renal replacement therapy landscape in 2030: reducing the global cardiovascular burden in dialysis patients.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2020
    Review
  14. Review
  15. Patient-Reported Outcomes: Toward Better Measurement of Patient-Centered Care in CKD.Journal of the American Society of Nephrology : JASN · 2019
    Article
  16. Expanding the Patient's Voice in Nephrology with Patient-Reported Outcomes.Journal of the American Society of Nephrology : JASN · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

John E WareJohn Ware Research Group, Outcomes Measurement Department, Watertown, Massachusetts; john.ware@jwrginc.com.ORCID 0000-0002-0744-2149
Michelle M RichardsonWilliam B. Schwartz Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts; and.
Klemens B MeyerWilliam B. Schwartz Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts; and.
Barbara GandekJohn Ware Research Group, Outcomes Measurement Department, Watertown, Massachusetts.

Funding

Functional Health CAT in Chronic Kidney DiseaseR44DK062555 · NIDDK · QUALITYMETRIC, INC. · PI WARE, JOHN E · 2006 to 2007
$1.4M
NIDDK NIH HHS R44 DK062555
6 · The paper itself

Abstract

backgroundPatient-reported outcome measures that are more practical and clinically useful are needed for patients with CKD. We compared a new CKD-specific quality-of-life impact scale (CKD-QOL) with currently used measures.

methodsPatients (

resultsKDQOL-36 and CKD-QOL measures generally discriminated better than generic SF-12v2 measures. The pattern of variances across CKD-specific tests comparing validity favored CKD-QOL two-fold over KDQOL-36. Two RV test results confirmed CKD-QOL improvements over the referent KDQOL scale. Results for static and CAT CKD-QOL forms were similar. SF-12 Physical and KDQOL-36 Symptoms scores worsened with increasing comorbid condition counts.

conclusionsOverall, compared with the KDQOL-36, the new approach to summarizing CKD-specific QOL impact performed better across multiple tests of validity. CAT surveys were more efficient than static surveys.

Indexed as

Patient Reported Outcome MeasuresQuality of LifeRenal Insufficiency, ChronicAdolescentAdultAgedCross-Sectional StudiesFemaleHealth StatusHumansInterpersonal RelationsKidney TransplantationMaleMiddle AgedRenal DialysisYoung Adultchronic kidney diseaseKDQOLPatient-Reported Outcomesquality of lifeSF-12 Health Survey

Identifiers

PMID30898870
PMCPMC6442339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.